Cas:935696-96-1 4-amino-5-chlorobenzofuran-7-carboxylic acid manufacturer & supplier

We serve Chemical Name:4-amino-5-chlorobenzofuran-7-carboxylic acid CAS:935696-96-1 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.

4-amino-5-chlorobenzofuran-7-carboxylic acid

Chemical Name:4-amino-5-chlorobenzofuran-7-carboxylic acid
CAS.NO:935696-96-1
Synonyms:4-Amino-5-chlorobenzofuran-7-carboxylic acid;4-Amino-5-chloro-1-benzofuran-7-carboxylic acid;7-Benzofurancarboxylic acid, 4-amino-5-chloro-
Molecular Formula:C9H6ClNO3
Molecular Weight:211.602
HS Code:2932999099

Physical and Chemical Properties:
Melting point:N/A
Boiling point:408.1±45.0 °C at 760 mmHg
Density:1.6±0.1 g/cm3
Index of Refraction:1.718
PSA:76.46000
Exact Mass:211.003616
LogP:2.67

Material Safety Information (Applicable for Hazard Chemicals)
RIDADR:
Packing Group:


Contact us for information like 4-Amino-5-chlorobenzofuran-7-carboxylic acid chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,7-Benzofurancarboxylic acid, 4-amino-5-chloro- physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,4-Amino-5-chloro-1-benzofuran-7-carboxylic acid Use and application,4-Amino-5-chloro-1-benzofuran-7-carboxylic acid technical grade,usp/ep/jp grade.


Related News: Given ICER’s uncertainty regarding efgartigimod’s dosing and long-term benefits, the group said it’s moderately certain the drug can produce a “comparable, small or substantial net health benefit” in that same group of MG patients. {2-[(E)-2-Chloro-acetylimino]-3-hydroxy-2,3-dihydro-thiazol-4-yl}-[(Z)-methoxyimino]-acetic acid ethyl ester manufacturers providing support for flexible, cross-sector training programmes to encourage more movement and collaboration between academia, industry and the charity sector mercaptomethyl-methyl-malonic acid diethyl ester suppliers Officials did, however, acknowledge that there’s growing evidence an extra jab may enhance the antibody response in immunocompromised people. Some small studies suggest up to 50% of people with no antibody response after the authorized regimen of two mRNA jabs developed a response after an additional dose, said CDC’s Sara Oliver, M.D. (1S,4S,7aS)-1-Hydroxy-4,7a-dimethyl-4-phenylsulfanylmethyl-1,2,4,6,7,7a-hexahydro-inden-5-one vendor & factory The little-known Italian company making the glass vials for most of the globe’s Covid-19 vaccines just scored a rare feat: a New York Stock Exchange IPO. It’s the biggest public offering for an Italian firm in the U.S. since Ferrari’s 2015 listing.,providing support for flexible, cross-sector training programmes to encourage more movement and collaboration between academia, industry and the charity sector